Medindia
Advertisement

Roche Will Pay $750 Million for Rights to 0P0595 Molecule That Boosts Efficiency of Antibiotics

by Dr. Trupti Shirole on January 14, 2015 at 11:35 PM

 Roche Will Pay $750 Million for Rights to 0P0595 Molecule That Boosts Efficiency of Antibiotics
Swiss pharmaceutical giant Roche will be paying up to $750 million for rights to a new molecule, 0P0595, is in the first phase of development that helps boost the efficiency of antibiotics to fight increasingly resistant bacteria. Roche said, "The deal with Japan's Meiji Seika Pharma and Canada's Fedora would allow us to develop and market beta-lactamase inhibitor OP0595 worldwide, except in Japan where Meiji will retain the rights."

Roche will make an initial payment to the two companies, a statement said without divulging the exact sum. But it added that the final payout could reach $750 million (636 million euros).
Advertisement

Approximately 65 percent of global antibiotic sales are of the beta-lactam class of antibiotics which includes penicillins, cephalosporins, monobactams and carbapenems. However, the efficacy of these life-saving antibiotics is threatened by rising bacterial resistance caused by beta-lactamase enzymes which render the antibiotics increasingly ineffective. The Centers for Disease Control (CDC) estimates that more than two million patients are affected by drug-resistant infections each year in the United States, with direct healthcare costs as high as $20 billion.

Janet Hammond from Roche's research unit said, "There is an urgent need for new antibiotics able to combat the increasing resistance to antibiotics that is being seen worldwide."

Christopher G. Micetich, founder and CEO of Fedora Pharmaceuticals said, "The properties of OP0595 and its ability to be combined with new or existing beta-lactam antibiotics promise a significant advance in the battle against increasing multi-drug-resistant bacteria."

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Type 2 Diabetes can be Controlled by Unripen Green Jackfruit Flour
Covid Pandemic: How Parents can Help Kids Deal with Back-to-School Anxiety
Do Covid Jabs Increase Risk of Miscarriage?
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
MRSA - The Super Bug Antibiotics Eye Infections Natural Antibiotics to Fight Bacterial Infections Vancomycin-Resistant Enterococci (VRE) 

Recommended Reading
Antibiotics
Antibiotics are among the most used and abused medications. This article explains some general ......
Natural Antibiotics to Fight Bacterial Infections
Fighting infections the natural way and preventing them is always more effective than consuming ......
Better Use of Antibiotics Could Help Fight the Superbugs
Proper use of antibiotics could help fight the infection Clostridium difficile - the superbug. ...
Avoid Antibiotics to Heal Naturally
A research in BioMed Central's open access journal BMC Family Practice found that given the o...
Eye Infections
Eye infection is a common problem that often causes pain and discomfort to the eyes. Common symptoms...
MRSA - The Super Bug
MRSA infection is the most dreaded hospital or community acquired infection that can become ......
Vancomycin-Resistant Enterococci (VRE)
Enterococci are a group of gram-negative bacteria that mostly inhabit the human gut. At present ther...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use